These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8886453)

  • 21. Thymidylate synthase: a critical target for cancer chemotherapy.
    Rose MG; Farrell MP; Schmitz JC
    Clin Colorectal Cancer; 2002 Feb; 1(4):220-9. PubMed ID: 12450420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic copy number changes affecting the thymidylate synthase (TYMS) gene in cancer: a model for patient classification to aid fluoropyrimidine therapy.
    Brody JR; Hucl T; Gallmeier E; Winter JM; Kern SE; Murphy KM
    Cancer Res; 2006 Oct; 66(19):9369-73. PubMed ID: 17018589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers.
    Raymond E; Buquet-Fagot C; Djelloul S; Mester J; Cvitkovic E; Allain P; Louvet C; Gespach C
    Anticancer Drugs; 1997 Oct; 8(9):876-85. PubMed ID: 9402315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antisense down-regulation of thymidylate synthase to suppress growth and enhance cytotoxicity of 5-FUdR, 5-FU and Tomudex in HeLa cells.
    Ferguson PJ; Collins O; Dean NM; DeMoor J; Li CS; Vincent MD; Koropatnick J
    Br J Pharmacol; 1999 Aug; 127(8):1777-86. PubMed ID: 10482907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
    van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
    Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms for 5-fluorouracil resistance in human colon cancer DLD-1 cells.
    Inaba M; Naoe Y; Mitsuhashi J
    Biol Pharm Bull; 1998 Jun; 21(6):569-73. PubMed ID: 9657039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of genomic factors beyond thymidylate synthase in the prediction of response to 5-fluorouracil.
    Peters GJ; Smid K; Meijer E; van Groeningen CJ; Leon LG
    Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):595-603. PubMed ID: 27906628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human dihydrofolate reductase and thymidylate synthase form a complex in vitro and co-localize in normal and cancer cells.
    Antosiewicz A; Jarmuła A; Przybylska D; Mosieniak G; Szczepanowska J; Kowalkowska A; Rode W; Cieśla J
    J Biomol Struct Dyn; 2017 May; 35(7):1474-1490. PubMed ID: 27187663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic modulation of thymidylate synthase gene expression and fluorouracil sensitivity in human colorectal cancer cells.
    Wakasa K; Kawabata R; Nakao S; Hattori H; Taguchi K; Uchida J; Yamanaka T; Maehara Y; Fukushima M; Oda S
    PLoS One; 2015; 10(4):e0123076. PubMed ID: 25881233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Fluorouracil targets thymidylate synthase in the selective suppression of TH17 cell differentiation.
    Wang J; Peng L; Zhang R; Zheng Z; Chen C; Cheung KL; Cui M; Bian G; Xu F; Chiang D; Hu Y; Chen Y; Lu G; Yang J; Zhang H; Yang J; Zhu H; Chen SH; Liu K; Zhou MM; Sikora AG; Li L; Jiang B; Xiong H
    Oncotarget; 2016 Apr; 7(15):19312-26. PubMed ID: 27027355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thymidylate synthase inhibition induces p53 dependent and independent cell death.
    Backus HH; Wouters D; van der Wilt CL; Kuiper CM; van Groeningen CJ; Pinedo HM; Peters GJ
    Adv Exp Med Biol; 2000; 486():303-6. PubMed ID: 11783505
    [No Abstract]   [Full Text] [Related]  

  • 32. Characterization and resistance mechanisms of a 5-fluorouracil- resistant hepatocellular carcinoma cell line.
    Gu W; Fang FF; Li B; Cheng BB; Ling CQ
    Asian Pac J Cancer Prev; 2012; 13(9):4807-14. PubMed ID: 23167424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: phenotypic and genotypic analyses.
    Etienne MC; Chazal M; Laurent-Puig P; Magné N; Rosty C; Formento JL; Francoual M; Formento P; Renée N; Chamorey E; Bourgeon A; Seitz JF; Delpero JR; Letoublon C; Pezet D; Milano G
    J Clin Oncol; 2002 Jun; 20(12):2832-43. PubMed ID: 12065560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy.
    Kinoshita M; Kodera Y; Hibi K; Nakayama G; Inoue T; Ohashi N; Ito Y; Koike M; Fujiwara M; Nakao A
    Anticancer Res; 2007; 27(2):851-6. PubMed ID: 17465211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of fluorouracil by N-(phosphonacetyl)-L-asparate: a review.
    Martin DS; Kemeny NE
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):49-55. PubMed ID: 1557657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined therapy with a thymidylate synthase-inhibiting vector and S-1 has effective antitumor activity against 5-FU-resistant tumors.
    Kadota K; Huang CL; Liu D; Yokomise H; Haba R; Wada H
    Int J Oncol; 2011 Feb; 38(2):355-63. PubMed ID: 21174056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphism in the thymidylate synthase promoter enhancer region is not an efficacious marker for tumor sensitivity to 5-fluorouracil-based oral adjuvant chemotherapy in colorectal cancer.
    Tsuji T; Hidaka S; Sawai T; Nakagoe T; Yano H; Haseba M; Komatsu H; Shindou H; Fukuoka H; Yoshinaga M; Shibasaki S; Nanashima A; Yamaguchi H; Yasutake T; Tagawa Y
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3700-4. PubMed ID: 14506161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of Fluoropirimidines in Gastrointestinal Tumours: from the Bench to the Bed.
    Hernando-Cubero J; Matos-García I; Alonso-Orduña V; Capdevila J
    J Gastrointest Cancer; 2017 Jun; 48(2):135-147. PubMed ID: 28397102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner.
    Hsueh CT; Kelsen D; Schwartz GK
    Clin Cancer Res; 1998 Sep; 4(9):2201-6. PubMed ID: 9748140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between gene expression of 5-fluorouracil metabolic enzymes and 5-fluorouracil sensitivity in primary cancer cells isolated from malignant ascites.
    Wang T; Wang L; Qian X; Yu L; Ding Y; Liu B
    Cancer Invest; 2011 Feb; 29(2):130-6. PubMed ID: 21210725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.